News | May 24, 2012

Unnecessary Surgeries Due To Induced Vasospasm Identified

May 24, 2012 — Research led by Christiana Care Health System's Andrew Doorey, M.D., has found that a small number of patients mistakenly undergo bypass surgery after diagnostic angiography.

The findings — presented May 10 in Las Vegas during the Society for Cardiovascular Angiography and Interventions' annual meeting — could determine a new way of clinical practice that could save patients from unnecessary operations and reduce healthcare costs.

The findings showed that some patients are erroneously diagnosed with having stenosis when they in fact have experienced a vasospasm.
Stenosis is the hardening and narrowing of the arteries. It is caused by a slow and progressive buildup of plaque under the lining of the arterial wall. Vasospasms, on the other hand, are spasms in the blood vessels' walls that are induced by a coronary catheter during a diagnostic angiography, a procedure that uses a special dye and X-rays to see how blood flows through the heart.

There is a difficulty in distinguishing a temporary blockage from a fixed blockage because both look identical, said Doorey, the study's principal investigator and a cardiologist with Christiana Care Cardiology Consultants. But the problem of the vasospasm in the critical left main artery had never been reported before and is now being brought to light.

Researchers examined 2,313 patients over a 10-year period. Among them, 385 patients had a subsequent catheterization at Christiana Hospital.

Sixteen of those 385 patients showed no signs of stenosis on a repeat study. Six of those 16 patients, however, underwent a coronary artery bypass graft surgery, the most commonly-performed open-heart operation to bypass blockages and obstructions. Since stenosis restricts bloodflow to the heart, a patient diagnosed with the condition is often immediately referred for surgery.

Instead of directing a patient with signs of stenosis immediately to surgery, doctors should take measures to ensure the patient be given intracoronary nitroglycerin, which can successfully treat the vasospasm. If the patient does not respond to the nitroglycerin, there is a stronger indication that the patient indeed has stenosis.

For more information:

Related Content

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
TherOx Gains FDA PMA Approval for SSO2 Therapy System
Technology | Cath Lab| September 29, 2017
September 29, 2017 — TherOx Inc. announced that the U.S.
Overlay Init